Exicure R&D Spending Growth & History (XCUR)
Exicure's r&d spending was $3.3M for fiscal 2025.
View full Exicure company overviewExicure annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $3.3M | $3.3M | — |
| 2024 | 2024-12-31 | $0 | −$1.4M | — |
| 2023 | 2023-12-31 | $1.4M | −$18.3M | −92.80% |
| 2022 | 2022-12-31 | $19.8M | −$29.2M | −59.64% |
| 2021 | 2021-12-31 | $49.0M | $16.9M | +52.61% |
| 2020 | 2020-12-31 | $32.1M | $12.8M | +65.95% |
| 2019 | 2019-12-31 | $19.3M | $5.2M | +36.98% |
| 2018 | 2018-12-31 | $14.1M | $1.0M | +7.94% |
| 2017 | 2017-12-31 | $13.1M | −$579,000 | −4.24% |
| 2016 | 2016-12-31 | $13.7M | — | — |
Exicure quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $174,000 | −$761,000 | −81.39% |
| Q1 2026 | 2026-03-31 | $312,000 | −$496,000 | −61.39% |
| Q4 2025 | 2025-12-31 | $655,000 | $655,000 | — |
| Q3 2025 | 2025-09-30 | $888,000 | $888,000 | — |
| Q2 2025 | 2025-06-30 | $935,000 | $935,000 | — |
| Q1 2025 | 2025-03-31 | $808,000 | $808,000 | — |
| Q4 2024 | 2024-12-31 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q2 2024 | 2024-06-30 | $0 | $0 | — |
| Q1 2024 | 2024-03-31 | $0 | −$1.4M | — |
| Q4 2023 | 2023-12-31 | $0 | −$1.1M | — |
| Q3 2023 | 2023-09-30 | $0 | −$4.8M | — |
| Q2 2023 | 2023-06-30 | $0 | −$6.7M | — |
| Q1 2023 | 2023-03-31 | $1.4M | −$5.7M | −80.07% |
| Q4 2022 | 2022-12-31 | $1.1M | −$10.3M | −90.60% |
| Q3 2022 | 2022-09-30 | $4.8M | −$11.7M | −70.80% |
| Q2 2022 | 2022-06-30 | $6.7M | −$4.1M | −37.76% |
| Q1 2022 | 2022-03-31 | $7.1M | −$3.1M | −30.42% |
| Q4 2021 | 2021-12-31 | $11.4M | $1.5M | +15.65% |
| Q3 2021 | 2021-09-30 | $16.5M | $7.3M | +80.07% |
| Q2 2021 | 2021-06-30 | $10.8M | $3.8M | +54.72% |
| Q1 2021 | 2021-03-31 | $10.3M | $4.2M | +68.92% |
| Q4 2020 | 2020-12-31 | $9.9M | $1.6M | +19.41% |
| Q3 2020 | 2020-09-30 | $9.1M | $4.9M | +115.29% |
| Q2 2020 | 2020-06-30 | $7.0M | $3.6M | +104.14% |
| Q1 2020 | 2020-03-31 | $6.1M | $2.7M | +78.94% |
| Q4 2019 | 2019-12-31 | $8.3M | $5.3M | +174.83% |
| Q3 2019 | 2019-09-30 | $4.2M | $244,000 | +6.10% |
| Q2 2019 | 2019-06-30 | $3.4M | −$402,000 | −10.48% |
| Q1 2019 | 2019-03-31 | $3.4M | $120,000 | +3.66% |
| Q4 2018 | 2018-12-31 | $3.0M | — | — |
| Q3 2018 | 2018-09-30 | $4.0M | $880,000 | +28.20% |
| Q2 2018 | 2018-06-30 | $3.8M | $534,000 | +16.18% |
| Q1 2018 | 2018-03-31 | $3.3M | −$213,000 | −6.11% |
| Q3 2017 · Sep 30 | 2017-09-30 | $3.1M | $708,000 | +29.34% |
| Q2 2017 · Jun 30 | 2017-06-30 | $3.3M | — | — |
| Q1 2017 | 2017-03-31 | $3.5M | — | — |
| Q3 2016 | 2016-09-30 | $2.4M | — | — |
Exicure r&d spending trends
Over the last five fiscal years, Exicure's r&d spending decreased from $32.1M to $3.3M, a change of −$28.8M. The latest reported quarter, Q2 2026, shows $174,000.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Exicure source filings ↗